Key Pharmaceuticals is an Australian-owned consumer healthcare company committed to driving growth in evidence-based over-the-counter (OTC) consumer healthcare products within Australia, New Zealand and export markets.
With origins dating back over 100 years, the current company was established in 1985 and has been providing Australian consumers with quality OTC consumer healthcare products for over 30 years.
We are a full-service business with a complete suite of in-house brand management capabilities, including sales and marketing, regulatory affairs, quality assurance, business development and warehousing.
Today, we are one of the leading independent Australian owned and based consumer healthcare companies and distributors of pharmaceutical products sold over-the-counter (OTC). We have an outstanding portfolio of leading consumer healthcare brands, a number of which are number one or two in their categories.
Everything we do is underpinned by our core values of integrity, quality, passion, and long term partnerships.
We demonstrate honesty, transparency and fairness in all our transactions with employees, business partners, customers and consumers.
We are passionate about the work we do and improving the health and wellbeing of consumers.
We are focused on bringing evidence-based products to the market, backed by a total commitment to quality.
We develop long standing relationships with our partners and are committed to long term value creation and success.
In addition to marketing and distributing consumer healthcare products owned by Key Pharmaceuticals, we also in-license products from other companies. We currently hold exclusive distribution arrangements with companies in the USA, Europe, Asia and Australia and are one of the leading Australian owned distributors of pharmaceutical products sold over-the-counter (OTC).
Our strong history of in-licensing, collaboration, innovation, and value creation makes us a partner of choice for overseas companies looking to develop their brand assets locally.
We are constantly looking for new ways to strengthen and grow our portfolio in OTC consumer healthcare products and medicines, therapeutic personal care products and medical devices, including by acquisition.